These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 32617076)
41. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Lavelle A; Sokol H Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145 [TBL] [Abstract][Full Text] [Related]
42. Aberrant frequency of IL-10-producing B cells and its association with the balance of Treg/Th17 in children with inflammatory bowel disease. Zhu XM; Huang YM; Fan JF; Shi YZ Pharmazie; 2015 Oct; 70(10):656-60. PubMed ID: 26601422 [TBL] [Abstract][Full Text] [Related]
43. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP; J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404 [TBL] [Abstract][Full Text] [Related]
44. CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production. Yu L; Yang F; Zhang F; Guo D; Li L; Wang X; Liang T; Wang J; Cai Z; Jin H Cell Death Dis; 2018 Sep; 9(9):905. PubMed ID: 30185773 [TBL] [Abstract][Full Text] [Related]
45. Expression of CCR6 and CXCR6 by Gut-Derived CD4 Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781 [TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs. Junginger J; Schwittlick U; Lemensieck F; Nolte I; Hewicker-Trautwein M Vet Res; 2012 Mar; 43(1):23. PubMed ID: 22440243 [TBL] [Abstract][Full Text] [Related]
47. Debugging the intestinal microbiota in IBD. Dessein R; Rosenstiel P; Chamaillard M Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S131-6. PubMed ID: 20117336 [TBL] [Abstract][Full Text] [Related]
48. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Michaudel C; Danne C; Agus A; Magniez A; Aucouturier A; Spatz M; Lefevre A; Kirchgesner J; Rolhion N; Wang Y; Lavelle A; Galbert C; Da Costa G; Poirier M; Lapière A; Planchais J; Nádvorník P; Illes P; Oeuvray C; Creusot L; Michel ML; Benech N; Bourrier A; Nion-Larmurier I; Landman C; Richard ML; Emond P; Seksik P; Beaugerie L; Arguello RR; Moulin D; Mani S; Dvorák Z; Bermúdez-Humarán LG; Langella P; Sokol H Gut; 2023 Jul; 72(7):1296-1307. PubMed ID: 36270778 [TBL] [Abstract][Full Text] [Related]
49. Intestinal Regulatory T Cells. Figliuolo da Paz VR; Jamwal DR; Kiela PR Adv Exp Med Biol; 2021; 1278():141-190. PubMed ID: 33523448 [TBL] [Abstract][Full Text] [Related]
50. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?! Pantazi E; Powell N Front Immunol; 2019; 10():676. PubMed ID: 31024537 [TBL] [Abstract][Full Text] [Related]
51. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment. Veltkamp C; Anstaett M; Wahl K; Möller S; Gangl S; Bachmann O; Hardtke-Wolenski M; Länger F; Stremmel W; Manns MP; Schulze-Osthoff K; Bantel H Gut; 2011 Oct; 60(10):1345-53. PubMed ID: 21459928 [TBL] [Abstract][Full Text] [Related]
53. Caspase recruitment domain 9, microbiota, and tryptophan metabolism: dangerous liaisons in inflammatory bowel diseases. Lamas B; Richard ML; Sokol H Curr Opin Clin Nutr Metab Care; 2017 Jul; 20(4):243-247. PubMed ID: 28399013 [TBL] [Abstract][Full Text] [Related]
54. Tryptophan and the innate intestinal immunity: Crosstalk between metabolites, host innate immune cells, and microbiota. Li Y; Liu N; Ge Y; Yang Y; Ren F; Wu Z Eur J Immunol; 2022 Jun; 52(6):856-868. PubMed ID: 35362153 [TBL] [Abstract][Full Text] [Related]
55. Oral Treatment with BT-11 Ameliorates Inflammatory Bowel Disease by Enhancing Regulatory T Cell Responses in the Gut. Leber A; Hontecillas R; Zoccoli-Rodriguez V; Chauhan J; Bassaganya-Riera J J Immunol; 2019 Apr; 202(7):2095-2104. PubMed ID: 30760618 [TBL] [Abstract][Full Text] [Related]
56. Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease. Russo E; Giudici F; Fiorindi C; Ficari F; Scaringi S; Amedei A Front Immunol; 2019; 10():2754. PubMed ID: 31824517 [TBL] [Abstract][Full Text] [Related]
57. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer. Velikova TV; Miteva L; Stanilov N; Spassova Z; Stanilova SA World J Gastroenterol; 2020 Apr; 26(16):1912-1925. PubMed ID: 32390702 [TBL] [Abstract][Full Text] [Related]
58. Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function. Boardman DA; Garcia RV; Ivison SM; Bressler B; Dhar TM; Zhao Q; Levings MK Eur J Immunol; 2020 Sep; 50(9):1400-1411. PubMed ID: 32388860 [TBL] [Abstract][Full Text] [Related]
59. Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation. Haq S; Grondin JA; Khan WI FASEB J; 2021 Oct; 35(10):e21888. PubMed ID: 34473368 [TBL] [Abstract][Full Text] [Related]
60. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]